Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Official Title: Evaluation of the Efficacy and the Cutaneous Acceptability of a Dermocosmetic Product in the Repigmentation of Vitiligo
In Brief: Comparative study, Lithium liposome versus placebo in intra-individual study.
Ages Eligible: 18 Years and older
Start Date: November 20, 2019
Completion Date (estimated): May 2020
Status: Enrolling by invitation
Study ID from ClinicalTrials.gov: NCT04171427
Other Study ID Numbers: 18E1721
Location: Hbib thamer Hospital, Tunis, Tunisia
Contact: To learn more about this study, you or your doctor may contact Dr. Samy FENNICHE. Please refer to this study by its NCT number.
FAQOther Questions
- PTSD in Vitiligo?
Living with vitiligo often involves dealing with more than just skin changes. Many people with vitiligo face discrimination, social stigma, and isolation, which can lead to lowe...
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Cont...
- Can a gluten-free diet help with vitiligo?
It's very unlikely. We have specifically looked into claims that gluten-free diet may ease symptoms of vitiligo, or completely reverse it, and found no firm scientific evidence ...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.